Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19
Standard
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19. / Messlinger, Karl; Neuhuber, Winfried; May, Arne.
in: CEPHALALGIA, Jahrgang 42, Nr. 2, 02.2022, S. 176-180.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19
AU - Messlinger, Karl
AU - Neuhuber, Winfried
AU - May, Arne
PY - 2022/2
Y1 - 2022/2
N2 - Clinical publications show consistently that headache is a common symptom in the coronavirus disease of 2019 (COVID-19). Several studies specifically investigated headache symptomatology and associated features in patients with COVID-19. The headache is frequently debilitating with manifold characters including migraine-like characteristics. Studies suggested that COVID-19 patients with headache vs. those without headache are more likely to have anosmia. We present a pathophysiological hypothesis which may explain this phenomenon, discuss current hypotheses about how the coronavirus SARS-CoV-2 enters the central nervous system and suggest that activation of the trigeminal nerve may contribute to both headache and anosmia in COVID-19.
AB - Clinical publications show consistently that headache is a common symptom in the coronavirus disease of 2019 (COVID-19). Several studies specifically investigated headache symptomatology and associated features in patients with COVID-19. The headache is frequently debilitating with manifold characters including migraine-like characteristics. Studies suggested that COVID-19 patients with headache vs. those without headache are more likely to have anosmia. We present a pathophysiological hypothesis which may explain this phenomenon, discuss current hypotheses about how the coronavirus SARS-CoV-2 enters the central nervous system and suggest that activation of the trigeminal nerve may contribute to both headache and anosmia in COVID-19.
U2 - 10.1177/03331024211036665
DO - 10.1177/03331024211036665
M3 - SCORING: Journal article
C2 - 34407648
VL - 42
SP - 176
EP - 180
JO - CEPHALALGIA
JF - CEPHALALGIA
SN - 0333-1024
IS - 2
ER -